
James Davis/X
Mar 5, 2025, 12:14
James Davis: Dexamethasone for CRS with teclistamab in R/R Multiple Myeloma
James Davis, Assistant professor and malignant hematology pharmacist at MUSC Hollings Cancer Center, shared an article he and his colleagues authored on X:
“Hot off the press!
Dexamethasone for CRS with teclistamab. You don’t need toci for grade 1 CRS! great team work.”
Authors: James Davis et al.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Mar 5, 2025, 13:46
Mar 5, 2025, 13:01
Mar 5, 2025, 13:01